Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,354.40 +121.18 0.80%
S&P 500 1,667.47 +17.00 1.03%
Nasdaq 3,498.97 +33.72 0.97%
Ticker Volume Price Price Delta
STOXX 50 2,817.99 +11.29 0.40%
FTSE 100 6,723.06 +35.26 0.53%
DAX 8,398.00 +28.13 0.34%
Ticker Volume Price Price Delta
Nikkei 15,347.00 +208.89 1.38%
Hang Seng 23,475.40 +392.71 1.70%
S&P/ASX 200 5,235.30 +54.53 1.05%
  • Fund Type: Open-End Fund
  • Objective: Sector Fund-Health & Biotech
  • Asset Class: Equity
  • Geographic Focus: Global

Danske Invest MediLife Fund

+ Add to Watchlist

MANMEDK:FH

820.11 EUR 0.000.00%

As of 01:59:30 ET on 05/16/2013.

Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Snapshot for Danske Invest MediLife Fund (MANMEDK)

Year To Date: +20.07% 3-Month: +13.02% 3-Year: +13.58% 52-Week Range: 647.45 - 828.80
1-Month: +4.70% 1-Year: +26.47% 5-Year: +11.94% Beta vs MXWO0PB: 0.81

Mutual Fund Chart for MANMEDK

No chart data available.
  • MANMEDK:FH 820.11
  • 1M
  • 1Y
Interactive MANMEDK Chart

Previous Close

Fund Profile & Information for MANMEDK

Danske Invest MediLife is an open-end fund registered in Finland. The Fund invests in pharmaceutical, biotechnology and medical technology and equipment companies worldwide. The Fund offers potential high yield, but also above average risk. The Fund's aim is to exceed the performance of the MSCI Pharmaceuticals -index \in the long term.

Inception Date: 08-15-2000 Telephone: 358-10-236-10
Managers: -
Web Site: www.sampopankki.fi

Fundamentals for MANMEDK

NAV (on 2013-05-16) 820.11
Assets (M) (on 2012-12-31) 30.31
Fund Leveraged N
Minimum Investment 500.00
Minimum Subsequent Investment 500.00

Dividends for MANMEDK

No dividends reported

Fees & Expenses for MANMEDK

Front Load 1.00
Back Load 1.00
Current Mgmt Fee 1.95
Redemption Fee 1.00
12b1 Fee -
Expense Ratio 1.95

Top Fund Holdings for MANMEDK

Filing Date: 02/28/2013
Name Position Value % of Total
Pfizer Inc 92,540 1,931,092 6.365%
Allergan Inc/United States 17,305 1,430,473 4.715%
Merck & Co Inc 43,020 1,401,528 4.619%
Vertex Pharmaceuticals Inc 38,725 1,382,361 4.556%
Eli Lilly & Co 28,705 1,196,261 3.943%
Team Health Holdings Inc 37,100 947,300 3.122%
Novo Nordisk A/S 6,753 906,631 2.988%
Sanofi 12,285 877,886 2.894%
Health Management Associates I 101,450 850,058 2.802%
UCB SA 18,727 824,175 2.716%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Financial Commentaries

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil